{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:37:01Z","timestamp":1787009821752,"version":"build-2736575974"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/aco.0b013e328363b4bf","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T12:26:34Z","timestamp":1377865594000},"page":"580-587","source":"Crossref","is-referenced-by-count":33,"title":["Neuropathic pain"],"prefix":"10.1097","volume":"26","author":[{"given":"Robert W.","family":"Hurley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith C.B.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honorio T.","family":"Benzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-11-20210129","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","article-title":"A new definition of neuropathic pain.","volume":"152","author":"Jensen","year":"2011","journal-title":"Pain"},{"key":"R3-11-20210129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations.","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"R4-11-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2007\/730785","article-title":"Pharmacological management of chronic neuropathic pain: consensus statement and guidelines from the Canadian Pain Society.","volume":"12","author":"Moulin","year":"2007","journal-title":"Pain Res Manag"},{"key":"R5-11-20210129","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol"},{"issue":"Suppl 1","key":"R6-11-20210129","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster.","volume":"44","author":"Dworkin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R7-11-20210129","first-page":"938","article-title":"Postherpetic neuralgia: a review of advances in treatment and prevention.","volume":"5","author":"Young","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"R8-11-20210129","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.medmal.2009.09.005","article-title":"Epidemiologic features of patients affected by herpes zoster: database analysis of the Ferrara University Dermatology Unit, Italy.","volume":"40","author":"Gabutti","year":"2010","journal-title":"Med Mal Infect"},{"key":"R9-11-20210129","doi-asserted-by":"crossref","first-page":"e1001420","DOI":"10.1371\/journal.pmed.1001420","article-title":"Herpes zoster vaccine effectiveness against incident herpes zoster and postherpetic neuralgia in an older US population: a cohort study.","volume":"10","author":"Langan","year":"2013","journal-title":"PLoS Med"},{"key":"R10-11-20210129","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jpain.2013.01.768","article-title":"A randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (PXN110748).","volume":"14","author":"Zhang","year":"2013","journal-title":"J Pain"},{"key":"R11-11-20210129","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2165\/11539520-000000000-00000","article-title":"Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study.","volume":"30","author":"Wallace","year":"2010","journal-title":"Clin Drug Investig"},{"key":"R12-11-20210129","first-page":"15","article-title":"Efficacy of pulsed radiofrequency in the treatment of thoracic postherpetic neuralgia from the angulus costae: a randomized, double-blinded, controlled trial.","volume":"16","author":"Ke","year":"2013","journal-title":"Pain Physician"},{"key":"R13-11-20210129","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1302\/0301-620X.87B12.16710","article-title":"Recent advances in the diagnosis and management of diabetic neuropathy.","volume":"87","author":"Rathur","year":"2005","journal-title":"J Bone Joint Surg Br"},{"key":"R14-11-20210129","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1464-5491.2002.00706.x","article-title":"A comparison of the neuropen against standard quantitative sensory: threshold measures for assessing peripheral nerve function.","volume":"19","author":"Paisley","year":"2002","journal-title":"Diabet Med"},{"key":"R16-11-20210129","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.2337\/dc12-0656","article-title":"Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life.","volume":"35","author":"Boyle","year":"2012","journal-title":"Diabetes Care"},{"key":"R17-11-20210129","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.diabres.2012.03.010","article-title":"A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial.","volume":"97","author":"Sandercock","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"R20-11-20210129","first-page":"51","article-title":"Pharmacodynamic analysis of the analgesic effect of capsaicin 8 patch (Qutenza) in diabetic neuropathic pain patients: detection of distinct response groups.","volume":"5","author":"Martini","year":"2012","journal-title":"J Pain Res"},{"key":"R21-11-20210129","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.pain.2012.06.024","article-title":"An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain.","volume":"153","author":"Toth","year":"2012","journal-title":"Pain"},{"key":"R22-11-20210129","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.pain.2012.04.014","article-title":"Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy.","volume":"153","author":"Campbell","year":"2012","journal-title":"Pain"},{"key":"R23-11-20210129","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/bja\/aes251","article-title":"Pain relief and quality-of-life improvement after spinal cord stimulation in painful diabetic polyneuropathy: a pilot study.","volume":"109","author":"Pluijms","year":"2012","journal-title":"Br J Anaesth"},{"key":"R24-11-20210129","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11912-007-0036-x","article-title":"Chemotherapy-induced neuropathy.","volume":"9","author":"Bhagra","year":"2007","journal-title":"Curr Oncol Rep"},{"key":"R27-11-20210129","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"key":"R28-11-20210129","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/annonc\/mdr045","article-title":"Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial.","volume":"23","author":"Durand","year":"2012","journal-title":"Ann Oncol"},{"key":"R29-11-20210129","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1200\/JCO.2012.42.1081","article-title":"Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain.","volume":"30","author":"Hardy","year":"2012","journal-title":"J Clin Oncol"},{"key":"R30-11-20210129","first-page":"841","article-title":"MMWR Morb Mortal Wkly R","volume":"55","year":"2006","journal-title":"ep"},{"key":"R31-11-20210129","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1529-8027.2001.006001008.x","article-title":"Epidemiology and clinical features of HIV-1 associated neuropathies.","volume":"6","author":"Verma","year":"2001","journal-title":"J Peripher Nerv Syst"},{"key":"R32-11-20210129","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/WNL.52.3.607","article-title":"Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy.","volume":"52","author":"Childs","year":"1999","journal-title":"Neurology"},{"key":"R33-11-20210129","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s00415-004-0529-6","article-title":"A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies.","volume":"251","author":"Hahn","year":"2004","journal-title":"J Neurol"},{"key":"R34-11-20210129","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1212\/WNL.0b013e3181ccc6ef","article-title":"Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial.","volume":"74","author":"Simpson","year":"2010","journal-title":"Neurology"},{"key":"R35-11-20210129","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/01.WNL.0000063304.88470.D9","article-title":"Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial.","volume":"60","author":"Simpson","year":"2003","journal-title":"Neurology"},{"key":"R36-11-20210129","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1097\/00126334-200412150-00010","article-title":"A randomized controlled trial of 5 lidocaine gel for HIV-associated distal symmetric polyneuropathy.","volume":"37","author":"Estanislao","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R37-11-20210129","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1212\/01.wnl.0000314647.35825.9c","article-title":"Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy.","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"R38-11-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-6405-10-5","article-title":"NGX-4010, a capsaicin 8 patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials.","volume":"10","author":"Brown","year":"2013","journal-title":"AIDS Res Ther"},{"key":"R39-11-20210129","first-page":"CD007393","article-title":"Topical capsaicin (high concentration) for chronic neuropathic pain in adults.","volume":"2","author":"Derry","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R40-11-20210129","first-page":"CD008242","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults.","volume":"12","author":"Moore","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R42-11-20210129","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1097\/BRS.0b013e318183a4a2","article-title":"Sciatica: review of epidemiological studies and prevalence estimates.","volume":"33","author":"Konstantinou","year":"2008","journal-title":"Spine (Phila Pa 1)"},{"key":"R43-11-20210129","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jbspin.2005.10.022","article-title":"Prevalence and risk factors of disk-related sciatica in an urban population in Tunisia.","volume":"73","author":"Younes","year":"2006","journal-title":"Joint Bone Spine"},{"key":"R44-11-20210129","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/00007632-199309010-00006","article-title":"The natural course of acute sciatica with nerve root symptoms in a double-blind placebo-controlled trial evaluating the effect of piroxicam.","volume":"18","author":"Weber","year":"1993","journal-title":"Spine (Phila Pa 1)"},{"key":"R45-11-20210129","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pain.2006.10.029","article-title":"Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain.","volume":"130","author":"Khoromi","year":"2007","journal-title":"Pain"},{"key":"R46-11-20210129","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jpain.2005.08.002","article-title":"Topiramate in chronic lumbar radicular pain.","volume":"6","author":"Khoromi","year":"2005","journal-title":"J Pain"},{"key":"R47-11-20210129","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.pain.2010.04.013","article-title":"The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy.","volume":"150","author":"Baron","year":"2010","journal-title":"Pain"},{"key":"R48-11-20210129","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1523\/JNEUROSCI.1742-12.2012","article-title":"Pain intensity the first year after lumbar disc herniation is associated with the A118G polymorphism in the opioid receptor mu 1 gene: evidence of a sex and genotype interaction.","volume":"32","author":"Olsen","year":"2012","journal-title":"J Neurosci"},{"key":"R49-11-20210129","doi-asserted-by":"crossref","first-page":"865","DOI":"10.7326\/0003-4819-157-12-201212180-00564","article-title":"Epidural corticosteroid injections in the management of sciatica: a systematic review and meta-analysis.","volume":"157","author":"Pinto","year":"2012","journal-title":"Ann Intern Med"},{"key":"R50-11-20210129","first-page":"790","article-title":"Long-term effects of pulsed radiofrequency on the dorsal root ganglion and segmental nerve roots for lumbosacral radicular pain: a prospective controlled randomized trial with nerve root block.","volume":"61","author":"Fujii","year":"2012","journal-title":"Masui"},{"key":"R51-11-20210129","doi-asserted-by":"crossref","first-page":"551","DOI":"10.7326\/0003-4819-156-8-201204170-00397","article-title":"Epidural steroids, etanercept, or saline in subacute sciatica: a multicenter, randomized trial.","volume":"156","author":"Cohen","year":"2012","journal-title":"Ann Intern Med"},{"key":"R52-11-20210129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/AAP.0b013e31828ea086","article-title":"Epidural steroids: a comprehensive, evidence-based review.","volume":"38","author":"Cohen","year":"2013","journal-title":"Reg Anesth Pain Med"},{"key":"R53-11-20210129","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2012.11.011","article-title":"Opioids for chronic pain: new evidence, new strategies, safe prescribing.","volume":"126","year":"2013","journal-title":"Am J Med"},{"key":"R54-11-20210129","first-page":"CD008025","article-title":"Methadone for chronic noncancer pain in adults.","volume":"11","author":"Haroutiunian","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R55-11-20210129","first-page":"CD009486","article-title":"Clonazepam for neuropathic pain and fibromyalgia in adults.","volume":"5","author":"Corrigan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R56-11-20210129","first-page":"CD007963","article-title":"Oxcarbazepine for neuropathic pain.","volume":"3","author":"Zhou","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R57-11-20210129","first-page":"CD008244","article-title":"Milnacipran for neuropathic pain and fibromyalgia in adults.","volume":"3","author":"Derry","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R58-11-20210129","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1185\/03007995.2013.792246","article-title":"Prospective, noninterventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8 cutaneous patch in 1044 patients with peripheral neuropathic pain. First results of the QUEPP study.","volume":"29","author":"Maihofner","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"R59-11-20210129","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.pain.2013.02.003","article-title":"A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia.","volume":"154","author":"Kalliomaki","year":"2013","journal-title":"Pain"},{"key":"R60-11-20210129","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/j.1532-2149.2012.00209.x","article-title":"Population pharmacokineticpharmacodynamic models for duloxetine in the treatment of diabetic peripheral neuropathic pain.","volume":"17","author":"Yuen","year":"2013","journal-title":"Eur J Pain"},{"key":"R63-11-20210129","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/STROKEAHA.111.671008","article-title":"Chronic pain syndromes after ischemic stroke: PRoFESS trial.","volume":"44","author":"ODonnell","year":"2013","journal-title":"Stroke"},{"key":"R65-11-20210129","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40261-013-0080-2","article-title":"Cross-over, open-label trial of the effects of gabapentin versus pregabalin on painful peripheral neuropathy and health-related quality of life in haemodialysis patients.","volume":"33","author":"Atalay","year":"2013","journal-title":"Clin Drug Investig"},{"key":"R67-11-20210129","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1212\/WNL.0b013e318281546b","article-title":"A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury.","volume":"80","author":"Cardenas","year":"2013","journal-title":"Neurology"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0b013e328363b4bf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T17:56:18Z","timestamp":1620928578000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001503-201310000-00011"}},"subtitle":["treatment guidelines and updates"],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0b013e328363b4bf","relation":{},"ISSN":["0952-7907"],"issn-type":[{"value":"0952-7907","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}